Isda’s Korean OTC law criticism
IFLR is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Isda’s Korean OTC law criticism

South Korea’s New Product Approval bill passed its first stage on February 16. The bill has been strongly opposed by Isda. Here are its concerns in full

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
Gift this article